Shares

19 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q2 2024

Aug 14, 2024

SELL
$53.58 - $57.02 $544,479 - $579,437
-10,162 Reduced 68.66%
4,638 $260,000
Q1 2024

May 15, 2024

SELL
$42.56 - $59.82 $101,931 - $143,268
-2,395 Reduced 13.93%
14,800 $835,000
Q4 2023

Feb 15, 2024

BUY
$32.18 - $46.57 $35,237 - $50,994
1,095 Added 6.8%
17,195 $772,000
Q3 2023

Nov 15, 2023

SELL
$44.2 - $50.2 $331,500 - $376,500
-7,500 Reduced 31.78%
16,100 $733,000
Q2 2023

Nov 13, 2023

SELL
$31.86 - $67.26 $5,129 - $10,828
-161 Reduced 0.68%
23,600 $1.02 Million
Q1 2023

May 11, 2023

BUY
$45.44 - $74.26 $71,886 - $117,479
1,582 Added 7.13%
23,761 $1.56 Million
Q4 2022

Feb 13, 2023

BUY
$41.39 - $81.0 $29,138 - $57,024
704 Added 3.28%
22,179 $997,000
Q3 2022

Nov 10, 2022

BUY
$72.36 - $113.1 $80,247 - $125,427
1,109 Added 5.45%
21,475 $1.55 Million
Q2 2022

Aug 08, 2022

BUY
$87.2 - $114.05 $110,918 - $145,071
1,272 Added 6.66%
20,366 $2.19 Million
Q1 2022

Apr 28, 2022

BUY
$94.19 - $124.49 $256,102 - $338,488
2,719 Added 16.6%
19,094 $2.12 Million
Q4 2021

Feb 11, 2022

BUY
$119.57 - $139.07 $119,211 - $138,652
997 Added 6.48%
16,375 $2.1 Million
Q3 2021

Nov 15, 2021

BUY
$109.17 - $142.35 $211,462 - $275,731
1,937 Added 14.41%
15,378 $2.05 Million
Q2 2021

Aug 16, 2021

BUY
$100.34 - $115.69 $319,382 - $368,241
3,183 Added 31.03%
13,441 $1.52 Million
Q1 2021

May 17, 2021

BUY
$101.51 - $125.27 $187,488 - $231,373
1,847 Added 21.96%
10,258 $1.08 Million
Q4 2020

Feb 16, 2021

BUY
$85.88 - $105.36 $513,562 - $630,052
5,980 Added 245.99%
8,411 $875,000
Q3 2020

Dec 01, 2020

SELL
$72.74 - $92.5 $20,949 - $26,640
-288 Reduced 10.59%
2,431 $216,000
Q2 2020

Aug 17, 2020

SELL
$48.02 - $79.04 $62,714 - $103,226
-1,306 Reduced 32.45%
2,719 $211,000
Q1 2020

May 18, 2020

BUY
$36.95 - $62.95 $61,078 - $104,056
1,653 Added 69.69%
4,025 $268,000
Q4 2019

May 18, 2020

BUY
$47.06 - $56.64 $111,626 - $134,350
2,372 New
2,372 $134,000

Others Institutions Holding CTLT

About Catalent, Inc.


  • Ticker CTLT
  • Exchange NYSE
  • Sector Healthcare
  • Industry Drug Manufacturers—Specialty & Generic
  • Shares Outstandng 179,896,000
  • Market Cap $11.4B
  • Description
  • Catalent, Inc., together with its subsidiaries, develops and manufactures solutions for drugs, protein-based biologics, cell and gene therapies, and consumer health products worldwide. The Softgel and Oral Technologies segment provides formulation, development, and manufacturing services for soft capsules for use in a range of customer products,...
More about CTLT
Track This Portfolio

Track Townsquare Capital LLC Portfolio

Follow Townsquare Capital LLC and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Townsquare Capital LLC, based on Form 13F filings with the SEC.

News

Stay updated on Townsquare Capital LLC with notifications on news.